Acoramidis Hydrochloride

3 trials 1 recruiting Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

13 Countries

Phase III

Phase III: 3

Sponsors using this IMP

Eidos Therapeutics Inc. 3

All trials

3 total

Extension Study of ACT-EARLY Pending

2024-513676-18-00 Phase III 11 countries Eidos Therapeutics Inc.
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Recruiting

2024-513547-82-00 Phase III 12 countries Eidos Therapeutics Inc.
An Open-Label Extension and Safety Monitoring Study of Acoramidis(AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopath… Ended

2024-515092-36-00 Phase III 9 countries Eidos Therapeutics Inc.

Showing 1–3 of 3 trials

← All drugs A–Z